← All companies

KAPA

Kairos Pharma, Ltd.

KAPA NYSE Pharmaceutical Preparations EDGAR ↗

$0.31

+0.01 +3.33%

Key statistics

from XBRL data in SEC filings

Market cap

$6.64M

Revenue (TTM)

—

Net income (TTM)

-$5.84M

EPS (TTM)

$-0.30

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$3.67M

Total assets

$5.74M

Gross margin

—

52-week range

$0.27 – $2.11

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Other events Jul 22, 2026 8-K Other events Jul 15, 2026 8-K Shareholder vote results Jun 30, 2026 8-K Other events Jun 4, 2026 8-K Other events May 18, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Entered a material agreement; Other events Mar 2, 2026 8-K Other events Feb 26, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change Oct 15, 2025 8-K Entered a material agreement; Other events Oct 7, 2025 8-K Other events Sep 18, 2025 8-K Other events Sep 11, 2025 8-K Other events Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 10-K/A Fiscal year ended 2024-12-31 Jul 28, 2025 8-K Other events Jul 15, 2025 8-K Entered a material agreement; Shareholder vote results Jun 12, 2025 8-K Other events Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 8-K Changed accountants Apr 28, 2025 8-K Other events Apr 24, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Other events Mar 20, 2025 8-K Other events Feb 26, 2025 8-K Other events Feb 6, 2025 8-K Entered a material agreement; Unregistered sale of equity Jan 17, 2025 8-K Entered a material agreement; Unregistered sale of equity Jan 14, 2025 8-K Director or officer change Dec 13, 2024 8-K Regulation FD disclosure Nov 19, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Other events Oct 10, 2024 8-K Entered a material agreement Oct 4, 2024 8-K Entered a material agreement Sep 27, 2024 8-K Entered a material agreement; Other events Sep 24, 2024 8-K Entered a material agreement; Regulation FD disclosure Sep 17, 2024

Other filings

DEFA14A May 26, 2026 ARS May 22, 2026